H
Hossein Baharvand
Researcher at University of Science and Culture
Publications - 487
Citations - 20462
Hossein Baharvand is an academic researcher from University of Science and Culture. The author has contributed to research in topics: Embryonic stem cell & Stem cell. The author has an hindex of 56, co-authored 454 publications receiving 15081 citations. Previous affiliations of Hossein Baharvand include Avicenna Research Institute & Royan Institute.
Papers
More filters
Journal ArticleDOI
Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model.
Reza Moghadasali,Reza Moghadasali,Mahnaz Azarnia,Mostafa Hajinasrollah,Hassan Arghani,Seyed Mahdi Nassiri,Mohammad Molazem,Ahmad Vosough,Soroush Mohitmafi,Soroush Mohitmafi,Mostafa Najarasl,Zahra Ajdari,Reza Salman Yazdi,Mohsen Bagheri,Hossein Ghanaati,B. Rafiei,Yousof Gheisari,Hossein Baharvand,Hossein Baharvand,Nasser Aghdami +19 more
TL;DR: These data demonstrate that BM-MSCs in this unique large-animal model of cisplatin-induced AKI exhibited recovery and protective properties.
Journal ArticleDOI
Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720)
TL;DR: Data indicate that repetitive treatment with FTY720, behind an anti-inflammatory effect, exerts beneficial effects on the process of endogenous repair of demyelinating insults.
Journal ArticleDOI
Basic fibroblast growth factor potentiates myelin repair following induction of experimental demyelination in adult mouse optic chiasm and nerves
Samaneh Dehghan,Mohammad Javan,Fereshteh Pourabdolhossein,Javad Mirnajafi-Zadeh,Hossein Baharvand +4 more
TL;DR: In this article, the effect of bFGF on lysolecithin-induced demyelination and remyelification processes in mouse optic chiasm and nerves was investigated.
Journal ArticleDOI
Concise review: harmonies played by MicroRNAs in cell fate reprogramming
TL;DR: In reviewing landmark roles of miRNAs in cell reprogramming, suggestions for evolution of the reprograming field are offered.
Journal ArticleDOI
Cell-based therapeutics for liver disorders.
TL;DR: Patient-specific cell therapy after the production of induced pluripotent stem cells and new discoveries in somatic cell conversion during transdifferentiation are promising insights.